Hansen, Scott G
Zak, Daniel E
Xu, Guangwu
Ford, Julia C
Marshall, Emily E
Malouli, Daniel
Gilbride, Roxanne M
Hughes, Colette M
Ventura, Abigail B
Ainslie, Emily
Randall, Kurt T
Selseth, Andrea N
Rundstrom, Parker
Herlache, Lauren
Lewis, Matthew S
Park, Haesun
Planer, Shannon L
Turner, John M
Fischer, Miranda
Armstrong, Christina
Zweig, Robert C
Valvo, Joseph
Braun, Jackie M
Shankar, Smitha
Lu, Lenette
Sylwester, Andrew W
Legasse, Alfred W
Messerle, Martin
Jarvis, Michael A
Amon, Lynn M
Aderem, Alan
Alter, Galit
Laddy, Dominick J
Stone, Michele
Bonavia, Aurelio
Evans, Thomas G
Axthelm, Michael K http://orcid.org/0000-0002-1984-5906
Früh, Klaus
Edlefsen, Paul T
Picker, Louis J
Article History
Received: 1 September 2017
Accepted: 15 December 2017
First Online: 15 January 2018
Competing interests
: OHSU, L.J.P., S.G.H., D.M. and K.F. have a significant financial interest in Vir Biotechnology, Inc., a company that may have a commercial interest in the results of this research and technology. The potential individual and institutional conflicts of interest have been reviewed and managed by OHSU. T.G.E. has served as a clinical consultant to Vir Biotechnology and also has a significant financial interest in that company.
Free to read: This content has been made available to all.